TrialCancer medicine2024

Avelumab first-line maintenance in advanced urothelial carcinoma: Complete screening for prognostic and predictive factors using machine learning in the JAVELIN Bladder 100 phase 3 trial.

Juliane Manitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.